Life Sciences Tools and Services
Company Overview of Rubicon Genomics, Inc.
Rubicon Genomics, Inc. engages in the development and commercialization of sample-specific nucleic acid library preparation products for use in research and clinical testing on next-generation sequencing (NGS), microarray, and q-PCR platforms. The company creates molecular biology tools for genetic, epigenetic, and expression analysis of various samples to facilitate gene-based research, drug development, and diagnostics. Its products include ThruPLEX DNA-seq kits to generate DNA libraries with expanded multiplexing capability and diversity with lower duplication rates; PicoPLEX DNA-seq kits to streamline library preparation and PicoPLEX process used by IVF clinics for pre-implantation genet...
4743 Venture Drive
Ann Arbor, MI 48108
Founded in 2000
Key Executives for Rubicon Genomics, Inc.
Chairman, Chief Executive Officer and President
Co-Founder and Chief Scientific Officer
Vice President of Business Development
Compensation as of Fiscal Year 2015.
Rubicon Genomics, Inc. Key Developments
Rubicon Genomics Reports Sales Results for the Year 2014
Feb 2 15
Rubicon Genomics, Inc. reported that sales increased 28% in 2014, fueled by new product introductions and new agreements with distributors in Europe, North Africa, North America and Asia.
Rubicon Genomics Adds New Global Distributors; Hires Karl Hecker as Vice President of Product Development
Oct 14 14
Rubicon Genomics, Inc. announced that it has signed agreements with new distributors in Europe, North Africa and Asia to further expand the availability of its DNA library preparation products for arrays and Illumina(R) next-generation sequencing (NGS) platforms, including ThruPLEX(R) DNA-seq, PicoPLEX(TM) DNA-seq, and PicoPLEX WGA Kits. Rubicon's new distributors include CliniSciences in France, Spain and North Africa; Nerliens Meszansky AS in Norway; Shanghai Nanodigmnio Biotechnology Co., Ltd, in China; and GeneLabs Life Science in Taiwan.
Rubicon announced that Karl Hecker, PhD, has joined the company as Vice President of Product Development. Dr. Hecker brings the Rubicon management team more than 15 years of life sciences and diagnostics product development expertise and over 25 years' experience in chemistry and molecular biology. At Invitrogen, he commercialized approximately 60 nucleic acid purification and isolation products in a three-year period.
Rubicon Genomics, Inc. Expands Distribution in Europe and Asia
Dec 12 13
Rubicon Genomics, Inc. announced that it has partnered with additional distributors globally to expand availability of its products, including ThruPLEX -FD Prep Kits and PicoPLEX-WGA Kits. Three new distribution partnerships have been signed for Europe. They include Amplitech for France, HPST for the Czech Republic and LuBio Science for Switzerland. Rubicon also completed new distribution agreements in Asia and the Middle East. They include Recenttec for Japan, Prisma Biotech for Taiwan and S.M. Chemical for Thailand. Custom Science will provide distribution services to Australia and New Zealand. A well-established local biomedical distributor is supporting sales of Rubicon's products in Qatar. ThruPLEX-FD Prep Kits for Illumina NGS platforms streamline library preparation for fragmented DNA/cDNA and reduce sample input amounts to picogram levels. ThruPlex-FD's patented technology delivers a highly efficient and user-friendly process that takes place in a single tube in less than 2 hours. ThruPLEX-FD provides consistent and reliable results for applications including DNA-seq, RNA-seq and ChiP-seq and is especially useful for clinical samples such as plasma and FFPE.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|